BIBLIOGRAPHIC RECORD

Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Suneeta Kumari; Hassan A Chaudhry; Adam J. Sagot; Stacy James Doumas; Hussain Muhammad Abdullah; Eric Alcera; Ramon Solhkhah; Saba Afzal
Source of metadata
OpenAlex
Year recorded
2024

Public identifiers and source

Open the source record

Reference

Suneeta Kumari; Hassan A Chaudhry; Adam J. Sagot; Stacy James Doumas; Hussain Muhammad Abdullah; Eric Alcera; Ramon Solhkhah; Saba Afzal. (2024). Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review. https://openalex.org/W4391734563

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-737bcb9d14f72470baaeee2bc03805aa/